Susp. Inj. cu Elib. Prel.

20 medicamente sub formă de susp. inj. cu elib. prel. autorizate în România.

Denumire comercială Substanță activă (DCI) Concentrație Producător Cod ATC
BYANNLI 1000 mg Paliperidonum 1000mg Janssen Pharmaceutica N.v. - Belgia N05AX13
BYANNLI 700 mg Paliperidonum 700mg Janssen Pharmaceutica N.v. - Belgia N05AX13
CAMCEVI 42 mg Leuprorelinum 42mg Accord Healthcare Polska Sp. Z O.o. - Polonia L02AE02
PALIPERIDONA TEVA 100 mg Paliperidonum 100mg Actavis Group Ptc Ehf. - Islanda N05AX13
PALIPERIDONA TEVA 150 mg Paliperidonum 150mg Actavis Group Ptc Ehf. - Islanda N05AX13
PALIPERIDONA TEVA 50 mg Paliperidonum 50mg Actavis Group Ptc Ehf. - Islanda N05AX13
PALIPERIDONA TEVA 75 mg Paliperidonum 75mg Actavis Group Ptc Ehf. - Islanda N05AX13
REKAMBYS 600 mg Rilpivirinum 600mg Janssen Pharmaceutica N.v. - Belgia J05AG05
REKAMBYS 900 mg Rilpivirinum 900mg Janssen Pharmaceutica N.v. - Belgia J05AG05
TREVICTA 175 mg Paliperidonum 175mg Janssen Pharmaceutica N.v. - Belgia N05AX13
TREVICTA 263 mg Paliperidonum 263mg Janssen Pharmaceutica N.v. - Belgia N05AX13
TREVICTA 350 mg Paliperidonum 350mg Janssen Pharmaceutica N.v. - Belgia N05AX13
TREVICTA 525 mg Paliperidonum 525mg Janssen Pharmaceutica N.v. - Belgia N05AX13
VOCABRIA 400 mg Cabotegravirum 400mg Glaxo Smithkline Manufacturing S.p.a. - Italia J05AJ04
VOCABRIA 600 mg Cabotegravirum 600mg Glaxosmithkline Manufacturing S.p.a. - Italia J05AJ04
Xeplion Paliperidonum 100mg Janssen Pharmaceutica N.v. - Belgia N05AX13
Xeplion Paliperidonum 150mg Janssen Pharmaceutica N.v. - Belgia N05AX13
Xeplion Paliperidonum 25mg Janssen Pharmaceutica N.v. - Belgia N05AX13
Xeplion Paliperidonum 50mg Janssen Pharmaceutica N.v. - Belgia N05AX13
Xeplion Paliperidonum 75mg Janssen Pharmaceutica N.v. - Belgia N05AX13

Forme similare